DEVELOPING: Healthcare workers in Tehran warn of potential medicine shortages as naval blockades and disruptions in the Strait of Hormuz hamper supply chains.
Healthcare workers in Tehran report concerns regarding potential medicine shortages as disruptions in the Strait of Hormuz impact supply chains.
What happened
Healthcare workers in Tehran report concerns regarding potential medicine shortages as disruptions in the Strait of Hormuz impact supply chains.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near Iran
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Regeneron reaches deal with Trump administration to lower drug prices and avoid planned tariffs. CEO Leonard Schleifer says the company aims to balance industry support with drug affordability.
Regeneron has reached an agreement with the Trump administration to reduce drug prices in exchange for avoiding planned tariffs. CEO Leonard Schleifer stated the company aims to support the industry while ensuring drug affordability.
Indian rupee hits lowest level in over a decade as regional conflict in Iran and portfolio outflows pressure the currency. The decline marks a significant shift for the Indian economy amid ongoing market volatility.
The Indian rupee has fallen to its lowest valuation in over a decade, driven by concerns over the war in Iran and significant portfolio outflows.
Mars FX US LP hedge fund files for bankruptcy as $600 million in assets go missing. The fund, managed by David Choi, previously reported average annual gains of 19% with no monthly losses.
David Choi's hedge fund, Mars FX US LP, has filed for bankruptcy with approximately $600 million in assets reported missing.
Merck & Co Inc launches a cash tender offer for Terns at $53.00 per share.
Merck & Co Inc has initiated a cash tender offer to acquire Terns at a price of $53.00 per share.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.